Scottsdale, AZ, Aug. 30, 2011 (GLOBE NEWSWIRE) -- -- PruGen, Inc. Pharmaceuticals announced today that it has been named to the 2011 Inc. 500. With a three-year sales growth of 6,412%, PruGen ranked 29th overall and 2nd in the healthcare category nationally. The list represents the most comprehensive look at the most important segment of the economy--America’s independent entrepreneurs. Companies such as Microsoft, Zappos, Intuit, Jamba Juice, Zipcar, Clif Bar, Vizio, Oracle, and many other well-known names gained early exposure as members of the Inc. 500.

Being recognized as the 29th fastest-growing private company in America on the 2011 Inc. 500 is a great honor. We are proud of our accomplishments to date and receiving recognition for those efforts is wonderful. We are a young, growing company looking forward to the future. Our product line expansion, research & development efforts, and increasing market penetration will help ensure that PruGen is a member of the Inc. 500 for years to come, says PruGen, Inc. president and CEO Sean Lonergan.

CONTACT:             For more information about PruGen, Inc., please contact Sean Lonergan at 480-585-0122 or


The 2011 Inc. 500 is ranked according to percentage revenue growth when comparing 2007 to 2010. To qualify, companies must have been founded and generating revenue by March 31, 2007. Additionally, they had to be U.S.-based, privately held, for profit, and independent--not subsidiaries or divisions of other companies--as of December 31, 2010. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2007 is $100,000; the minimum for 2010 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at

About Inc. Magazine

Founded in 1979 and acquired in 2005 by Mansueto Ventures LLC, Inc. ( is the only major business magazine dedicated exclusively to owners and managers of growing private companies that delivers real solutions for today’s innovative company builders. With a total paid circulation of 710,106, Inc. provides hands-on tools and market-tested strategies for managing people, finances, sales, marketing, and technology. Visit us online at

About PruGen, Inc.

PruGen, Inc. develops, manufactures, and markets generic and branded prescription and over-the-counter medications. The Company also performs research and development in areas such as drug delivery technology for oral medications, and advanced treatments for fungal infections, acne, and rosacea. Notably, the Company received a government grant last year under the Qualifying Therapeutic Discovery Program. Visit us at

For more information about PruGen, Inc., please contact Sean Lonergan at 480-585-0122 or